You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Sulforaphane modulation of oligomeric amyloid-
- In: Posters D - Formulation Design and Pharmaceutical Technology
- At: PSWC, Melbourne (Australia) (2014)
- Type: Poster
- Poster code: PD-105
- By: GIULIANI, Angelo (University of Bologna, Pharmacology, Bologna, Italy)
- Co-author(s): Hrelia (University of Bologna, Bologna, Italy)
Tarozzi (University of Bologna, Bologna, Italy) - Abstract:
Alzheimer's disease (AD) is the most common neurodegenerative disease.
The AD is characterized by the anomalous formation of the neurotoxic
peptide amyloid-β (Aβ) in hippocampal and cortical regions of the brain.
In particular, Aβ1-42 peptides can exist in multiple aggregation forms including soluble oligomers
which are associated with oxidative.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026